PeptideDB

AK 275

CAS No.: 158798-83-5

AK 275 is a calpain inhibitor that prevents degradation of cytoskeletal and myelin proteins in spinal cord in vitro.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description AK 275 is a calpain inhibitor that prevents degradation of cytoskeletal and myelin proteins in spinal cord in vitro.
Synonyms AK275, AK-275
molecular weight 377.48
Molecular formula C20H31N3O4
CAS 158798-83-5
Storage Powder: -20°C for 3 years | In solvent: -80°C for 1 year
References 1. James T, Matzelle D, Bartus R, Hogan EL, Banik NL. New inhibitors of calpain prevent degradation of cytoskeletal and myelin proteins in spinal cord in vitro. J Neurosci Res. 1998 Jan 15;51(2):218-22. PubMed PMID: 9469575. 2. Zalewska T. Calpain as proposed target for neuroprotective treatment of brain ischemia. Folia Neuropathol. 1996;34(3):121-7. Review. PubMed PMID: 8946783. 3. Bartus RT, Baker KL, Heiser AD, Sawyer SD, Dean RL, Elliott PJ, Straub JA. Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage. J Cereb Blood Flow Metab. 1994 Jul;14(4):537-44. PubMed PMID: 8014200.